Nasus Pharma Ltd. (NYSEAMERICAN:NSRX – Get Free Report) fell 1.2% on Wednesday . The company traded as low as $3.87 and last traded at $4.05. Approximately 4,462 shares changed hands during trading, a decline of 73% from the average daily volume of 16,376 shares. The stock had previously closed at $4.10.
Nasus Pharma Stock Performance
The business has a 50 day simple moving average of $3.35 and a 200-day simple moving average of $3.41.
Nasus Pharma (NYSEAMERICAN:NSRX – Get Free Report) last issued its quarterly earnings results on Monday, August 17th. The company reported ($0.27) earnings per share for the quarter. On average, equities research analysts predict that Nasus Pharma Ltd. will post -0.93 earnings per share for the current year.
Nasus Pharma Company Profile
Nasus Pharma Ltd. is a clinical-stage pharmaceutical company focused on the development of innovative intranasal products to treat emergency medical conditions. Nasus Pharma Ltd. is based in TEL AVIV, Israel.
Featured Articles
- Five stocks we like better than Nasus Pharma
- 3 Financial Stocks Positioned for the Fed’s Next Move After Jackson Hole
- IREN’s AI Pivot Looks Real, But the Market Wanted a Faster Payoff After Earnings
- Boeing’s $131B F-15 Win: Mach 1 Momentum or Just Altitude?
- Okta Stock Surges 29%—Is $200 the Next Stop?
Receive News & Ratings for Nasus Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nasus Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
